Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AOTI, Inc. ( (GB:AOTI) ) has provided an update.
AOTI, Inc. announced that its Chief Financial Officer, Jayesh Pankhania, purchased 31,250 common shares, increasing his stake to 0.03% of the company’s issued share capital. This transaction, conducted on the London Stock Exchange, reflects confidence in the company’s market position and potential growth, potentially impacting stakeholder perceptions positively.
More about AOTI, Inc.
AOTI, Inc., founded in 2006 and based in Oceanside, California, and Galway, Ireland, specializes in innovative solutions for severe and chronic wound care. The company’s patented Topical Wound Oxygen (TWO2®) therapy has been proven to significantly reduce the recurrence of Diabetic Foot Ulcers, hospitalizations, and amputations, with regulatory approvals across several countries.
Average Trading Volume: 42,355
Technical Sentiment Signal: Strong Sell
Current Market Cap: £85.09M
For detailed information about AOTI stock, go to TipRanks’ Stock Analysis page.